Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
4.2600
-0.0900
(-2.07%)
As of 12:32:13 PM GMT+1. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-41,382.6120
-36,002.0890
-19,613.7150
-20,316.7560
-5,767.3620
Investing Cash Flow
-168.8240
-278.0850
-9,975
--
--
Financing Cash Flow
65,737.5170
40,988.3970
8,369.1860
52,456.1030
--
End Cash Position
30,415.7010
23,101.0790
18,392.8550
39,612.3840
7,473.0380
Capital Expenditure
-168.8240
-278.0850
-9,975
--
--
Issuance of Capital Stock
73,557.3260
46,767.3180
3,501.6270
56,117.0720
--
Issuance of Debt
--
--
5,000
--
--
Repayment of Debt
-5,000
-5,000
--
--
--
Free Cash Flow
-41,551.4360
-36,280.1740
-29,588.7150
-20,316.7560
-5,767.3620
6/30/2021 - 10/23/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
O33.F Glycorex Transplantation AB (publ)
0.2030
0.00%
DMYD-B.ST Diamyd Medical AB (publ)
9.99
-0.10%
ATORX.ST Alligator Bioscience AB (publ)
0.0544
-20.35%
FARON.HE Faron Pharmaceuticals Oy
1.9720
-1.89%
PRLD Prelude Therapeutics Incorporated
0.7590
+1.88%
TRVI Trevi Therapeutics, Inc.
4.5200
+0.44%
RPTX Repare Therapeutics Inc.
1.1800
-1.67%
CAMP CAMP4 THERAPEUTICS CORPORATION
4.9100
+30.93%
OSRH OSR Holdings, Inc.
3.0400
-8.43%
ALDX Aldeyra Therapeutics, Inc.
5.11
-19.40%